Energy & Commerce Committee restructuring
Executive Summary
House Energy & Commerce Committee will focus on oversight functions under new Chairman Joe Barton (R-Texas). Medicaid and Medicare costs will be one focus. Rep. Billy Tauzin (R-La.) resigned as chair Feb. 18 (1"The Pink Sheet" March 1, 2004, p. 23). Staffing changes are also underway; Chief Health Counsel Patrick Morrisey is leaving Capitol Hill to join law firm Sidley Austin Brown & Wood...
You may also be interested in...
PhRMA CEO Search On Hold; Tauzin Will Wait On Decision
Rep. Billy Tauzin (R-La.) has suspended discussions with the Pharmaceutical Research & Manufacturers of America to become the trade association's CEO, his office said Feb. 26
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.